Ginkgo Biloba is suspected of causing endocrine-disrupting effects, according to European Commission Annex 13. Includes both Category 1 (evidence for endocrine disruption in living organisms) and Category 2 (evidence of potential to cause endocrine disruption in in vitro studies)
Ginkgo Biloba is suspected of causing cancer, according to official classification designated under an EU regulation known as EU - CLP (1272/2008) as well as those designated by the International Agency for the Research on Cance (IARC) as IARC Group 2B (Possibly Carcinogenic to Humans) substances.
It is not on any of GoodGuide’s lists of toxic chemicals which cause suspected or recognized health effects.
It has not been detected in human tissue or urine.